Vor Biopharma (VOR) Gets a Hold from Robert W. Baird
Robert W. Baird analyst Jack Allen maintained a Hold rating on Vor Biopharma (VOR – Research Report) today and set a price target of $1.00. The company's shares closed today at $0.89.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Allen covers the Healthcare sector, focusing on stocks such as Vor Biopharma, Bluebird Bio, and Fate Therapeutics. According to TipRanks, Allen has an average return of -21.2% and a 27.08% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Vor Biopharma with a $0.32 average price target, which is a -64.04% downside from current levels. In a report released today, Wedbush also maintained a Hold rating on the stock with a $0.40 price target.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 hours ago
- Business Insider
GM workers in Mexico vote to join Carlos Leone union, Bloomberg says
Workers at a General Motors (GM) SUV plant in Mexico have voted in favor of joining the Carlos Leone union, David Welch and Amy Stillman of Bloomberg reports. Carlos Leone was elected to represent GM's 6,500 workers in San Luis Potosi. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Business Insider
2 hours ago
- Business Insider
Goldman ICBC Wealth joint venture CEO to leave company, Bloomberg says
The CEO of Goldman Sachs (GS) ICBC Wealth Management Alex Wang is leaving the company and may join Japanese rival Nomura Holdings (NMR), Cathy Chan of Bloomberg reports, citing people familiar with the matter. This is as the company struggles to gain a foothold in China's asset management market. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Business Insider
2 hours ago
- Business Insider
Serbia says China to increase exports of materials for EVs, Bloomberg says
Serbia has received assurances from China that it would support increasing exports of materials critical for EV production, Misha Savic of Bloomberg reports. This move will benefit companies such as Stellantis (STLA), which operates a factory in the Balkan country, President Aleksandar Vucic said, according to Bloomberg. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
